Glenmark Life Sciences Limited
NSE: GLS BSE: 543322 SECTOR: Healthcare - Pharmaceuticals & Biotechnology
1060 9(-1%)
Volume
22k as on 06, Jan
Open
1,065
High
1,074
Low
1,052
Close
1,069
VWAP
1,022
52 Week High
1,335
52 Week Low
819
Quality Score
00/00
Growth Score
00/00
Valuation Score
00/00
Momentum Score
00/00
Analyst Recommendations
BUY/SELL
|
|
Analyst Price Target
-
Market Cap (cr)
13,307
No. of Shares
P/E
31.38
P/B
5.23
Face Value
2
Div. Yield
-
Book Value (TTM)
-
CASH
-
DEBT
-
EPS (TTM)
-
ROE
16.68
ROCE
-
Profit Growth
-
Listing Date
06-Aug-21
Promoter Holding
74.91%
FII Holding
5.08%
DII Holding
7.13%
Price Chart
Price Performance
1 Week5%
1 Month4%
3 Months12%
6 Months12%
1 Year25%
YTD0%
Moving Average
5 Day SMA1,016
10 Day SMA997
20 Day SMA1,012
30 Day SMA1,035
50 Day SMA1,044
61 Day SMA1,063
80 Day SMA1,089
200 Day SMA0
PIVOT LEVEL
| Standard | Camarilla | Fibonacci | Woodie's | |
|---|---|---|---|---|
| Resistance 3 | 1,084 | 1,041 | 1,070 | 1,081 |
| Resistance 2 | 1,070 | 1,038 | 1,057 | 1,068 |
| Resistance 1 | 1,051 | 1,034 | 1,049 | 1,047 |
| Pivot Point | 1,036 | 1,031 | 1,036 | 1,034 |
| Support 1 | 1,017 | 1,028 | 1,023 | 1,013 |
| Support 2 | 1,002 | 1,025 | 1,015 | 1,000 |
| Support 3 | 983 | 1,022 | 1,002 | 979 |
Competitors/Peers
| # | Symbol | MCAP | LTP | 1W | 1M | 6M | 1Y | P/E | Ind PE | Debt/Eq | Div Yld % | NP Qtr Rs.Cr. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | 4,42,187 | 1843 | 2% | 14% | 2% | 9% | 39 | 0 | 0 | 0 | |
| 2 | DIVISLAB | 1,80,280 | 6791 | 2% | 6% | 4% | 1% | 65 | 0 | 0 | 0 | |
| 3 | TORNTPHARM | 1,53,281 | 4529 | 0% | 8% | 18% | 40% | 64 | 0 | 0 | 0 | |
| 4 | APOLLOHOSP | 1,19,047 | 8280 | 3% | 7% | 12% | 17% | 58 | 0 | 0 | 0 | |
| 5 | CIPLA | 1,14,869 | 1422 | 1% | 10% | 7% | 4% | 22 | 0 | 0 | 0 | |
| 6 | DRREDDY | 1,11,015 | 1330 | 0% | 1% | 7% | 7% | 20 | 0 | 0 | 0 | |
| 7 | ZYDUSLIFE | 1,09,378 | 1087 | 6% | 16% | 15% | 17% | 20 | 0 | 0 | 0 | |
| 8 | LUPIN | 1,04,017 | 2275 | 1% | 2% | 9% | 15% | 23 | 0 | 0 | 0 | |
| 9 | MANKIND | 1,00,482 | 2434 | 3% | 7% | 7% | 2% | 49 | 0 | 0 | 0 | |
| 10 | MAXHEALTH | 96,867 | 995 | 7% | 1% | 15% | 14% | 0 | 0 | 0 | 0 | |
| Load More | ||||||||||||
Quarterly Results
Profit and Loss
| Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|
| Sales | 1885 | 1537 | 886 |
| Expenses | 1294 | 1065 | 639 |
| Operating Profit | 591 | 472 | 248 |
| OPM % | 31 | 31 | 28 |
| Other Income | 1 | 12 | 0 |
| Interest | 88 | 34 | 1 |
| Depreciation | 33 | 29 | 19 |
| Profit before tax | 471 | 421 | 228 |
| Tax % | 25 | 26 | 14 |
| Net Profit | 352 | 313 | 196 |
| EPS in Rs | 358.74 | 1597.37 | 997.86 |
| Dividend Payout % | 0 | 0 | 0 |
Cash Flows
| Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|
| Cash from Operating Activity | 0 | 0 | 0 |
| Cash from Investing Activity | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 |
Balance Sheet
| Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|
| Equity Capital | 0 | 0 | 0 |
| Reserves | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 |
| Total Assets | 0 | 0 | 0 |
Delivery
Daily Market Cap
No records found.
Stock Checklist
Price is below from 52 week high low average: 7%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO